| Financial Year |
March 31 2023 |
| Monetary Funds |
916,858,927.89 |
| Held-for-trading Financial Assets |
1,230,486.60 |
| Notes Receivable |
327,828,885.33 |
| Accounts Receivable |
670,129,273.56 |
| Advances to Suppliers |
73,268,695.67 |
| Other Receivables |
3,201,785.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,330,094,650.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
206,721,086.66 |
| Total Current Assets |
4,688,964,248.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,155,604.45 |
| Fixed Assetes |
2,385,849,719.99 |
| Under-construction Projects |
154,958,787.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
149,733,672.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
367,039.78 |
| Deferred Income Tax Assets |
192,992,768.44 |
| Other Non-Current Assets |
479,852,982.04 |
| Sub-Total of Non-Current Assets |
3,733,942,897.13 |
| Total Assets |
8,422,907,145.15 |
| Short-Term Loans |
535,191,462.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
844,800,232.60 |
| Accounts Payable |
1,725,332,258.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,179,926.78 |
| Taxes Payable |
11,381,544.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,969,414.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,879,940.88 |
| Other Current Liabilities |
205,705,638.63 |
| Sub-Total of Current Liabilities |
3,434,585,411.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
44,572,079.61 |
| Deferred Income Tax Liabilities |
117,698,125.07 |
| Other Non-Current Liabilities |
376,687,777.73 |
| Sub-Total of Non-Current Liabilities |
689,604,150.54 |
| Total Liabilities |
4,124,189,562.08 |
| Paid-In Capital(Or Share Stock) |
1,219,223,766.00 |
| Capital Surplus |
2,844,900,821.02 |
| Surplus Reserve |
166,513,455.56 |
| LESS:Treasury Stock |
14,135,325.00 |
| Undistributed Profits |
49,373,494.60 |
| Minority Stockholder's Interest |
31,648,564.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,267,069,018.98 |
| Owner's Equity（Stockholder's Equity） |
4,298,717,583.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,422,907,145.15 |
